Electroencephalographic Power Spectral Density Profile of the Orexin Receptor Antagonist Suvorexant in Patients with Primary Insomnia and Healthy Subjects

STUDY OBJECTIVES: Suvorexant, an orexin receptor antagonist, improves sleep in healthy subjects (HS) and patients with insomnia. We compared the electroencephalographic (EEG) power spectral density (PSD) profile of suvorexant with placebo using data from a phase 2 trial in patients with insomnia. We...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ma, Junshui, Svetnik, Vladimir, Snyder, Ellen, Lines, Christopher, Roth, Thomas, Herring, W. Joseph
Format: Artigo
Idioma:Inglês
Publicat: Associated Professional Sleep Societies, LLC 2014
Matèries:
EEG Power Spectral Density of the Orexin Receptor Antagonist Suvorexant
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4173918/
https://ncbi.nlm.nih.gov/pubmed/25197807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5665/sleep.4068
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars